Fusion Pharmaceuticals Inc

The Evolution of Radiopharmaceuticals - Fusion Pharma - Home

The evolution of radiopharmaceuticals. Fusion Pharma is using targeted alpha therapeutics to improve the safety of radiopharmaceuticals.

Acquisition of Fusion completed - AstraZeneca

AstraZeneca today announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company.

AstraZeneca to acquire Fusion to accelerate the development of ...

AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next- ...

Acquisition of Fusion Pharmaceuticals Completed - PR Newswire

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation RCs. Fusion connects alpha particle emitting ...

Fusion Pharmaceuticals Inc. - SEC.gov

Fusion Pharmaceuticals Inc. · This company's Exchange Act registration has been revoked · This company's Exchange Act registration as a Municipal Advisor has ...

Fusion Pharmaceuticals | LinkedIn

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision ...

S-1 - SEC.gov

Fusion Pharmaceuticals Inc. (Exact name of registrant as specified in its charter). Canada*, 2836, Not Applicable. (State or other jurisdiction of incorporation ...

Fusion Pharmaceuticals Inc - Company Profile and News - Bloomberg

Company profile page for Fusion Pharmaceuticals Inc including stock price, company news, executives, board members, and contact information.

AstraZeneca bets on next-generation cancer therapy with $2 bln ...

AstraZeneca said on Tuesday it will buy Canadian drug developer Fusion Pharmaceuticals Inc for $2 billion in cash as the Anglo-Swedish ...

Fusion Pharma: Home

Fusion Pharma Limited - Bespoke consultancy services within the pharmaceutical industry - Regulatory Affairs - Quality Assurance - Pharmacovigilance and ...

Fusion Pharmaceuticals Inc - Company Profile - GlobalData

Fusion Pharmaceuticals Inc (Fusion Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops targeted alpha-particle radio therapeutics for ...

Fusion Pharmaceuticals - Crunchbase Company Profile & Funding

The company was acquired by AstraZeneca in a deal valued at up to $2.4 billion, indicating a significant valuation and investment in its radiopharmaceuticals ...

Acquisition | FUSION PHARMACEUTICALS INC | 4th June 2024

ASTRAZENECA PLC made a cash offer for FUSION PHARMACEUTICALS INC of USD 21 per FUSION PHARMACEUTICALS INC share held.

Fusion Pharmaceuticals Company Profile 2024 - PitchBook

Manufacturer of radiopharmaceuticals focused on developing next-generation radiopharmaceuticals as precision medicines. The company specializes in targeted ...

AstraZeneca to Buy Fusion Pharmaceuticals for Up to $2.4B as Firm ...

KEY TAKEAWAYS · AstraZeneca Plc (AZN) on Tuesday said it will acquire biotech company Fusion Pharmaceuticals Inc. · Ontario-based Fusion specializes in next- ...

Fusion Pharmaceuticals and Point Biopharma Global Initiation

William Blair initiated research coverage of Fusion Pharmaceuticals Inc. (FUSN $2.53) and POINT Biopharma Global Inc. (PNT $6.81), two companies in what ...

Fusion Pharmaceuticals to be Acquired by AstraZeneca ...

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as ...

Fusion Pharmaceuticals, Inc. - Patsnap Synapse

Synapse is a global drug intelligence database for pharmaceutical companies, investment institutions and industrial parks. It provides complete and ...

Fusion Pharmaceuticals Inc. - BioWorld

Fusion raises $60M to acquire phase II radiopharma asset targeting prostate cancer ... Radiopharmaceutical company Fusion Pharmaceuticals Inc. is acquiring a ...

Fusion Pharmaceuticals Inc. | Institution outputs | Nature Index

Research. Date range: 1 August 2023 - 31 July 2024. No articles found. Fusion Pharmaceuticals Inc. did not contribute to ...